PhaseV vs Upstream Bio
PhaseV vs Upstream Bio, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: PhaseV is on 56/100 and Upstream Bio on 61/100.
Where each one leads
PhaseV
- headcount growth: +173.2% against +43.4%
Upstream Bio
- our overall score: 61/100 against 56/100
- funding raised: $400M against $65.0M
- LinkedIn following: 11,799 against 6,602
At a glance
| Measure | PhaseV | Upstream Bio |
|---|---|---|
| What it is | Develops a platform for adaptive clinical trial design and closed-loop execution. | Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases. |
| Category | Life Sciences, Clinical Trials, Optimization, HealthTech | Life Sciences, Therapeutics, Biotech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 2023 | 2021 |
| Headquarters | Tel Aviv, Israel | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | PhaseV | Upstream Bio |
|---|---|---|
| Employees | 61 | 75 |
| Headcount growthLast 12 months | +173.2% | +43.4% |
| Total funding | $65.0M | $400M |
| Latest round | Series A | Series B |
| LinkedIn followers | 6,602 | 11,799 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | PhaseV | Upstream Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 61/100 |
| Traction | 57/100 | 59/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 40/100 | 37/100 |
| Quality | 55/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 33/100 | 32/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | PhaseV | Upstream Bio |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Webflow | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Google Analytics 4 | Google Tag Manager |
PhaseV vs Upstream Bio: common questions
Which is better, PhaseV or Upstream Bio?
On our 0-100 score Upstream Bio rates higher (61/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do PhaseV and Upstream Bio compare on the numbers?
PhaseV leads on headcount growth (+173.2% against +43.4%). Upstream Bio leads on our overall score (61/100 against 56/100), funding raised ($400M against $65.0M), LinkedIn following (11,799 against 6,602).
Read the full PhaseV review and pricing or the Upstream Bio review and pricing. You can also browse other PhaseV alternatives we track.